Beacon Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Beacon Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,579	Closed	-$443K	–	185
2016 Q3	$443K	Buy	9,579 +1,689	+21%	+$88.1K	0.09%	139
2016 Q2	$397K	Sell	7,890 -59	-0.7%	-$3.14K	0.09%	134
2016 Q1	$432K	Sell	7,949 -3,097	-28%	-$182K	0.09%	129
2015 Q4	$729K	Buy	+11,046	New	+$683K	0.17%	83

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Beacon Financial Group's TEVA Position: Q4 2016 in Review

Beacon Financial Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 9,579 shares — an estimated $443K sold.

Beacon Financial Group first reported a position in TEVA in Q4 2015 and held it in 4 quarters. The position peaked at $729K in Q4 2015. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Beacon Financial Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
Beacon Financial Group sold 9,579 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $443K.
Beacon Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 4 quarters.
Beacon Financial Group's Teva Pharmaceutical Industries Limited position peaked at $729K in Q4 2015.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on Beacon Financial Group's 13F filing for Q4 2016, filed 5 Jan 2017.